Biopolym. Cell. 1989; 5(2):74-78.
Cell Biology
Cholesterol effect on Apolipoprotein B secretion and binding of low-density lipoproteins hepatoma HepG2 Cells
1Fuki I. V., 1Preobrazhensky S. N., 1Misharin A. Yu., 1Bushmakina N. G., 1Menshchikov G. B., 1Repin V. S.
  1. Research Institute of Experimental Cardiology, National Cardiological Research Centre, Academy of Medical Sciences of the USSR
    Moscow, USSR

Abstract

The effect of cholesterol, oleic acid and recombinant complexes containing apolipoprotein Al/dimyristoylphosphatidylcholine (apoAl/DMPC) on apolipoprotein B (apoB) secretion and uptake of 125I-labeled low-density lipoproteins (LDL) by cultured human hepatoma HepG2 cells was studied. Addition of different concentrations of exogenous cholesterol (as ethanol solution) to the cells increased apoB secretion and inhibited 1 25I-labelled LDL uptake in a dose-dependent manner. Similar effects were found when the cells were incubated with different concentrations of oleic acid, which enhanced the intracellular cholesterol content. The presence of complexes apoAl/DMPC in the culture medium, which decreased the cellular pool of cholesterol, resulted in the opposite effects: apoB secretion was inhibited, while the LDL-receptor activity was stimulated. Significant negative correlation (r = —0.92, p<0.001) was found between apoB secretion and LDL uptake. The obtained data suggest that cholesterol can induce cooperated changes in apoB secretion and LDL-rcceptor activity.

References

[1] Edge SB, Hoeg JM, Schneider PD, Brewer HB Jr. Apolipoprotein B synthesis in humans: liver synthesizes only apolipoprotein B-100. Metabolism. 1985;34(8):726-30.
[2] Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25(12):1277-94.
[3] Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
[4] Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A. 1980;77(1):604-8.
[5] Kosykh VA, Preobrazhensky SN, Fuki IV, Zaikina OE, Tsibulsky VP, Repin VS, Smirnov VN. Cholesterol can stimulate secretion of apolipoprotein B by cultured human hepatocytes. Biochim Biophys Acta. 1985;836(3):385-9.
[6] Preobrazhensky SN, Ivanov VO, Fuki IV, Tsibulsky VP, Kameneva AM, Repin VS, Ermolin GA. Enzyme-linked immunoreceptor assay of low-density-lipoprotein receptors. Anal Biochem. 1985;149(1):269-74.
[7] Stephens RE. High-resolution preparative SDS-polyacrylamide gel electrophoresis: fluorescent visualization and electrophoretic elution-concentration of protein bands. Anal Biochem. 1975;65(1-2):369-79.
[8] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-75.
[9] Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972;260(2):212-21.
[10] Antonov IV, Medvedeva NV, Misharin AJu, Morozkin AD, Ruuge EK. Recombinant models of lipoproteins. Apolipoprotein A-I/phosphatidylcholine/cholesterol complexes formed in a 2-chloroethanol-water mixture. Biochim Biophys Acta. 1985;835(1):50-7.
[11] Preobrazhensky SN, Tsibulsky VP, Fuki IV, Ivanov VO, Repin VS, Smirnov VN. Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem. 1986;154(2):382-7.
[12] Ellsworth JL, Erickson SK, Cooper AD. Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid. J Lipid Res. 1986;27(8):858-74.
[13] Orekhov AN, Misharin AYu, Tertov VV, Khashimov KhA, Pokrovsky SN, Repin VS, Smirnov VN. Artificial HDL as an anti-atherosclerotic drug. Lancet. 1984;2(8412):1149-50.
[14] Lutalo-Bosa AJ, Adolphson JL, Albers JJ. Evaluation of the measurement of B protein of plasma low density lipoprotein by radial immunodiffusion. J Lipid Res. 1985;26(8):995-1001.